Items Tagged ‘Dr. Yi Lin’

August 6, 2019

Mayo Clinic Startup Earns World Economic Forum Award

By Susan Buckles Susan Buckles (@susanbuckles)

With the promise of potential lifesaving treatments like chimeric antigen receptor (CAR) T-Cell therapy comes complex challenges. For instance: how can we be sure the right cells are going to the right patient? How can we communicate problems with manufacturing that would affect a patient’s treatment schedule? To address those concerns, Mayo Clinic startup company […]

View full entry

Tags: #Andrew Danielsen, #CAR T-cell therapy, #Dr. Jeffrey Winters, #Mayo Clinic Department of Laboratory Medicine and Pathology, #Mayo Clinic Ventures, #The World Economic Forum, #Vineti, Dr. Allan Dietz, Dr. Yi Lin, Mayo Clinic Center for Regenerative Medicine

November 9, 2017

CAR T-Cell Therapy for Relapsed Non-Hodgkin Lymphoma

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

This story first appeared on the Mayo Clinic News Network. Mayo Clinic announced recently that its Rochester campus is one of 16 cancer centers nationally selected to provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for adults with B-cell non-Hodgkin lymphoma who have not responded to, or have relapsed, after two or more lines of treatment. The therapy, […]

View full entry

Tags: axicabtagene ciloleucel, B-cell non-Hodgkin lymphoma, Dr. Lin, Dr. Yi Lin, Mayo Clinic CAR T-cell therapy, Medical Research, Minnesota News Releases, News Releases, Non-Hodgkin Lymphoma, regenerative immunotherapy, Yescarta, Yi Lin

Contact Us · Privacy Policy